Progression-free survival down with antibiotic use for patients receiving immune checkpoint inhibitors
Your search for bevacizumab returned 124 results
Genentech announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin alone, for the treatment of patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
A post-hoc analysis of a randomized clinical trial comparing three anti-vascular endothelial growth factor (VEGF) agents, found that intravitreous aflibercept was associated with the greatest improvement in visual acuity (VA) over 2 years, for patients with diabetic macular edema (DME).
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment, according to a study published online in Clinical Cancer Research.
Saline as good as medications for hereditary hemorrhagic telangiectasia, researchers find
A recent article published in the journal American Family Physician discusses the important role family physicians play in helping to identify vision loss in older patients.
Approximately 20% of autoimmune-uveitis cases are associated with systemic autoimmune diseases.
Not only are prescription agents known to affect heart failure (HF), various over-the-counter and complementary medications have also been associated with causing or worsening HF as well.
Survival odds for colorectal cancer may depend on which side of the colon the primary tumor develops, according to a study released Wednesday during a media briefing that previewed some of the research to be presented at the upcoming annual meeting of the American Society of Clinical Oncology.
Herpes simplex uveitis ID’d as cause of persistently elevated intraocular pressure after cataract sx